Versigent (NYSE:VGNT) Stock Rating Lowered by Fox Advisors

Versigent (NYSE:VGNT) was downgraded by investment analysts at Fox Advisors from an “overweight” rating to an “equal weight” rating in a research note issued on Wednesday, MarketBeat.com reports.

Other analysts also recently issued reports about the stock. Zacks Research raised shares of Versigent from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 2nd. BNP Paribas Exane assumed coverage on shares of Versigent in a report on Tuesday, April 28th. They set an “outperform” rating and a $41.00 price target on the stock. The Goldman Sachs Group initiated coverage on shares of Versigent in a research note on Monday, July 20th. They issued a “buy” rating and a $48.00 price objective for the company. Wells Fargo & Company upped their price objective on shares of Versigent from $42.00 to $48.00 and gave the stock an “overweight” rating in a report on Thursday, June 25th. Finally, Oppenheimer set a $50.00 target price on shares of Versigent in a research report on Tuesday, July 21st. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $50.58.

Versigent Price Performance

Shares of Versigent stock opened at $45.81 on Wednesday. The firm’s 50-day moving average price is $43.38. Versigent has a 52-week low of $26.34 and a 52-week high of $50.88.

Versigent (NYSE:VGNT) last released its quarterly earnings data on Tuesday, August 4th. The company reported $1.92 EPS for the quarter, topping analysts’ consensus estimates of $1.58 by $0.34. The firm had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.29 billion.